Sort   by:  
 Page size 
ProteomicsCorramycin mode of action in Escherichia coli and mycobacterium tuberculosis
Corramycin mode of action in Escherichia coli and mycobacterium tuberculosis. Proteome comparison of corramycin treated vs untreated bacterial protein expression
ORGANISM(S): Mycobacterium tuberculosis H37Rv Escherichia coli 
2026-08-13 | PXD060283 | Pride
Escherichia coli Mycobacterium tuberculosis Corramycin Mode of action 
ProteomicsCystobactamid resistant clinical isolates
Generated cystobactamid resistant clinical isolates of E. coli compared to WT show YgiV upregulation and fimbrial downregulation
ORGANISM(S): Escherichia coli 
2024-10-11 | PXD051732 | Pride
Cystobactamids Amr Clinical isolates E. coli 
ProteomicsThe RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages
The RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages
ORGANISM(S): Homo sapiens (Human) 
2024-10-11 | PXD052287 | Pride
Extracellular vesicles Igf2bp2 Human 
ProteomicsPharmacological and toxicological investigations of cystobactamids reveal binding and inhibition of HCV entry receptor SCARB1
Affinity-based protein profiling of cystobactamids in HEK293 and HeLa cells
ORGANISM(S): Homo sapiens (Human) 
2025-10-29 | PXD052895 | Pride
Scarb1 Hcv Cystobactamid Liver 
Sort   by:  
 Page size